Deutsche Bank
HCAT icon

Deutsche Bank’s Health Catalyst HCAT Stock Holding History

Deutsche Bank’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43K Sell
21,587
-202,906
-90% -$293K ﹤0.01% 3580
2026
Q1 		$285K Sell
224,493
-36,789
-14% -$69.2K ﹤0.01% 2847
2025
Q4 		$624K Buy
261,282
+49,657
+23% +$136K ﹤0.01% 2456
2025
Q3 		$603K Sell
211,625
-63,183
-23% -$216K ﹤0.01% 2451
2025
Q2 		$1.04M Buy
274,808
+55,370
+25% +$218K ﹤0.01% 2071
2025
Q1 		$994K Sell
219,438
-6,330
-3% -$33.5K ﹤0.01% 2160
2024
Q4 		$1.6M Buy
225,768
+19,659
+10% +$157K ﹤0.01% 1983
2024
Q3 		$1.68M Buy
206,109
+9,760
+5% +$70.5K ﹤0.01% 1865
2024
Q2 		$1.25M Sell
196,349
-11,352
-5% -$72.9K ﹤0.01% 1879
2024
Q1 		$1.56M Buy
207,701
+855
+0.4% +$7.8K ﹤0.01% 1786
2023
Q4 		$1.92M Buy
206,846
+173,116
+513% +$1.41M ﹤0.01% 1710
2023
Q3 		$341K Sell
33,730
-172,716
-84% -$2.06M ﹤0.01% 2421
2023
Q2 		$2.58M Sell
206,446
-11,125
-5% -$132K ﹤0.01% 1506
2023
Q1 		$2.54M Buy
217,571
+8,716
+4% +$111K ﹤0.01% 1556
2022
Q4 		$2.22M Buy
208,855
+5,585
+3% +$53.9K ﹤0.01% 1599
2022
Q3 		$1.97M Sell
203,270
-45,736
-18% -$606K ﹤0.01% 1625
2022
Q2 		$3.61M Buy
249,006
+17,723
+8% +$302K ﹤0.01% 1446
2022
Q1 		$6.04M Buy
231,283
+169,949
+277% +$4.82M ﹤0.01% 1317
2021
Q4 		$2.43M Sell
61,334
-367,042
-86% -$16.7M ﹤0.01% 1876
2021
Q3 		$21.4M Sell
428,376
-278,017
-39% -$15.2M 0.01% 872
2021
Q2 		$39.2M Sell
706,393
-29,733
-4% -$1.58M 0.02% 678
2021
Q1 		$34.4M Buy
736,126
+443,737
+152% +$21.5M 0.02% 708
2020
Q4 		$12.7M Sell
292,389
-83,840
-22% -$3.09M 0.01% 943
2020
Q3 		$13.8M Buy
376,229
+95,263
+34% +$3.24M 0.01% 829
2020
Q2 		$8.2M Buy
280,966
+274,360
+4,153% +$7.58M 0.01% 1063
2020
Q1 		$173K Buy
6,606
+3,638
+123% +$111K ﹤0.01% 3018
2019
Q4 		$102K Buy
2,968
+606
+26% +$20.1K ﹤0.01% 3568
2019
Q3 		$73K Buy
+2,362
New +$93K ﹤0.01% 3727

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's HCAT Position: Q2 2026 in Review

Deutsche Bank reduced its Health Catalyst (HCAT) stake by 90% in Q2 2026, selling an estimated $293K and leaving 21,587 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #3580.

Deutsche Bank first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $39.2M in Q2 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Deutsche Bank held 21,587 shares of Health Catalyst worth $43K as of Q2 2026.
  • Deutsche Bank sold 202,906 Health Catalyst shares in Q2 2026, an estimated $293K.
  • Health Catalyst made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3580 holding.
  • Deutsche Bank first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • Deutsche Bank's Health Catalyst position peaked at $39.2M in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.